Pittsbugh, PA, United States of America

Yolanda Colson


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2000

Loading Chart...
1 patent (USPTO):Explore Patents

Title: **Yolanda Colson: Innovating Monoclonal Antibodies in Hematopoietic Research**

Introduction

Yolanda Colson is an esteemed inventor based in Pittsburgh, PA, recognized for her significant contributions to the field of monoclonal antibody research. With a focus on hematopoietic facilitatory cells, Colson's innovative work has paved the way for advancements in medical research and applications.

Latest Patents

Colson holds one patent for her groundbreaking invention titled "Monoclonal Antibodies to Antigens Expressed by Hematopoietic." This patent relates to the development of monoclonal antibodies (MAb) aimed at hematopoietic facilitatory cells. The invention specifically targets antigens expressed by murine FC, providing remarkable methods for generating these antibodies and utilizing them in various applications. The MAbs developed have profound implications, enabling researchers to rapidly isolate FC, identify them in donor cell preparations, and even molecularly clone the genes encoding corresponding target antigens.

Career Highlights

Yolanda Colson is currently affiliated with the University of Pittsburgh, where she continues her research and innovation in the field of biomedical sciences. Her knowledge and expertise have made a significant impact on the study of hematopoietic cells and their applications in medicine.

Collaborations

Throughout her career, Colson has collaborated with notable colleagues, including Suzanne T Ildstad and Christina Kaufman. These collaborations enhance her research endeavors, pushing boundaries in scientific understanding and application.

Conclusion

Yolanda Colson is a pioneering inventor whose work with monoclonal antibodies addresses critical challenges in hematopoietic research. Her contributions not only advance scientific knowledge but also facilitate practical applications that have the potential to improve patient care and outcomes. As she continues her innovative journey at the University of Pittsburgh, the impact of her work is poised to resonate across various fields in biomedical research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…